Cite
HARVARD Citation
Calzada, O. et al. (2018). Deferred treatment is a safe and viable option for selected patients with mantle cell lymphoma. Leukemia & lymphoma. 59 (12), pp. 2862-2870. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Calzada, O. et al. (2018). Deferred treatment is a safe and viable option for selected patients with mantle cell lymphoma. Leukemia & lymphoma. 59 (12), pp. 2862-2870. [Online].